iShares Biotechnology ETF News
Biotech Stocks Are Cheap. Is It Time for Blockbuster M&A?
Valuations for biotech stocks have slumped. This in particular opens up great opportunities for mergers and acquisitions.
Shares of CRISPR Therapeutics Fall in After Hours Trading on Share Offering
Stock had risen shaply during regular session on gene therapy progress.
3 Investments You Are Probably Not Considering, But Should Be
Even with the market looking wobbly, there are good bargains to be found. Here are several suggestions from TheStreet's newsroom.
Biogen Sparks Hope on Treating Alzheimer's Disease: Everything You Must Know
Biogen delivered promising results on a new Alzheimer's disease treatment. And investors rewarded the company accordingly.
Investors With an Appetite for Risk Could Find Big Gains In Biotech ETFs
The biotech industry can offer high rewards for those willing to bite at the opportunity. Here's how to play it through an ETF.
Biohaven Pharma's New Migraine Drug Shows Promise in Late-Stage Test Results
Shares have fallen 5% since Monday, but Phase III trials for a new drug were encouraging.
New Opportunities in Biotech: Cramer's 'Off the Charts'
The beaten down biotech sector may offer more opportunities in this newly volatile market environment.
Tips for Retirees to Deal with Falling Stocks and Bonds
The markets' slide particularly hurts retirees, who may have to sell some of their stocks and bonds to finance spending.
Alphabet CEO Pichai Continues to Sound Alarm About the Economy
The parent company of Google and Youtube is preparing for a sharp deterioration in the health of the economy.